REQUEST A DEMO
Total
USD $0.00
Search more companies

Hermes Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hermes Laboratories Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hermes Laboratories Private Limited is a pharmaceutical company specializing in the development, manufacture, and marketing of basic drug intermediates and specialty chemicals in domestic and international markets. The company is known for its expertise in high vacuum distillations and aims to be the primary supplier to leading pharmaceutical companies.

Legal Address
C.32,Kssidc Industrialestate, Veerapura Po, Doddaballapur.
Bangalore; Karnataka; Postal Code: 561203

Contact Details: Purchase the Hermes Laboratories Private Limited report to view the information.

Website: http://www.hermeslab.in

Basic Information
Total Employees:
Purchase the Hermes Laboratories Private Limited report to view the information.
Outstanding Shares:
Purchase the Hermes Laboratories Private Limited report to view the information.
Registered Capital:
Purchase the Hermes Laboratories Private Limited report to view the information.
Incorporation Date:
August 09, 2001
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Company Performance
Financial values in the chart are available after Hermes Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
1.36%
Total operating revenue
1.39%
Operating profit (EBIT)
-20.65%
EBITDA
-15.43%
Net Profit (Loss) for the Period
-19.05%
Total assets
17.44%
Total equity
8.56%
Operating Profit Margin (ROS)
-0.48%
Net Profit Margin
-0.33%
Return on Equity (ROE)
-2.69%
Debt to Equity Ratio
-3.51%
Quick Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?